Logo image of SNES

SENESTECH INC (SNES) Stock Fundamental Analysis

NASDAQ:SNES - Nasdaq - US81720R6045 - Common Stock - Currency: USD

2.17  -0.01 (-0.46%)

Fundamental Rating

3

Overall SNES gets a fundamental rating of 3 out of 10. We evaluated SNES against 198 industry peers in the Pharmaceuticals industry. Both the profitability and financial health of SNES have multiple concerns. SNES shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

SNES had negative earnings in the past year.
SNES had a negative operating cash flow in the past year.
In the past 5 years SNES always reported negative net income.
SNES had a negative operating cash flow in each of the past 5 years.
SNES Yearly Net Income VS EBIT VS OCF VS FCFSNES Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5M -10M -15M

1.2 Ratios

The Return On Assets of SNES (-188.65%) is worse than 87.37% of its industry peers.
With a Return On Equity value of -246.28%, SNES is not doing good in the industry: 71.72% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -188.65%
ROE -246.28%
ROIC N/A
ROA(3y)-145.81%
ROA(5y)-129.68%
ROE(3y)-183.8%
ROE(5y)-169.9%
ROIC(3y)N/A
ROIC(5y)N/A
SNES Yearly ROA, ROE, ROICSNES Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500 -1K -1.5K

1.3 Margins

SNES has a better Gross Margin (54.07%) than 63.64% of its industry peers.
In the last couple of years the Gross Margin of SNES has grown nicely.
The Profit Margin and Operating Margin are not available for SNES so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 54.07%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.57%
GM growth 5Y13.61%
SNES Yearly Profit, Operating, Gross MarginsSNES Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5K -10K -15K -20K

More info and screens

3

2. Health

2.1 Basic Checks

SNES does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, SNES has more shares outstanding
Compared to 5 years ago, SNES has more shares outstanding
The debt/assets ratio for SNES is higher compared to a year ago.
SNES Yearly Shares OutstandingSNES Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200K 400K 600K 800K 1M
SNES Yearly Total Debt VS Total AssetsSNES Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

2.2 Solvency

Based on the Altman-Z score of -60.04, we must say that SNES is in the distress zone and has some risk of bankruptcy.
SNES has a worse Altman-Z score (-60.04) than 92.42% of its industry peers.
SNES has a Debt/Equity ratio of 0.08. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of SNES (0.08) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF N/A
Altman-Z -60.04
ROIC/WACCN/A
WACC9.79%
SNES Yearly LT Debt VS Equity VS FCFSNES Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M -10M

2.3 Liquidity

SNES has a Current Ratio of 5.01. This indicates that SNES is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of SNES (5.01) is better than 72.73% of its industry peers.
SNES has a Quick Ratio of 3.60. This indicates that SNES is financially healthy and has no problem in meeting its short term obligations.
SNES has a better Quick ratio (3.60) than 62.12% of its industry peers.
Industry RankSector Rank
Current Ratio 5.01
Quick Ratio 3.6
SNES Yearly Current Assets VS Current LiabilitesSNES Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 96.76% over the past year.
SNES shows a strong growth in Revenue. In the last year, the Revenue has grown by 55.40%.
Measured over the past years, SNES shows a very strong growth in Revenue. The Revenue has been growing by 67.70% on average per year.
EPS 1Y (TTM)96.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%86.49%
Revenue 1Y (TTM)55.4%
Revenue growth 3Y45.73%
Revenue growth 5Y67.7%
Sales Q2Q%69.83%

3.2 Future

The Earnings Per Share is expected to grow by 14.28% on average over the next years. This is quite good.
Based on estimates for the next years, SNES will show a very strong growth in Revenue. The Revenue will grow by 76.45% on average per year.
EPS Next Y36.16%
EPS Next 2Y18.6%
EPS Next 3Y14.28%
EPS Next 5YN/A
Revenue Next Year103.47%
Revenue Next 2Y91.38%
Revenue Next 3Y76.45%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
SNES Yearly Revenue VS EstimatesSNES Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2M 4M 6M 8M 10M
SNES Yearly EPS VS EstimatesSNES Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 -10K -20K -30K -40K -50K

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SNES. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SNES. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SNES Price Earnings VS Forward Price EarningsSNES Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SNES Per share dataSNES EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -2 -4 -6 -8

4.3 Compensation for Growth

A more expensive valuation may be justified as SNES's earnings are expected to grow with 14.28% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y18.6%
EPS Next 3Y14.28%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SNES!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SENESTECH INC

NASDAQ:SNES (4/25/2025, 2:14:58 PM)

2.17

-0.01 (-0.46%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)03-12 2025-03-12/amc
Earnings (Next)05-07 2025-05-07
Inst Owners2.2%
Inst Owner Change0%
Ins Owners0.02%
Ins Owner Change0%
Market Cap3.80M
Analysts82.86
Price Target10.2 (370.05%)
Short Float %14.93%
Short Ratio1.95
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)28.42%
Min EPS beat(2)20.26%
Max EPS beat(2)36.58%
EPS beat(4)3
Avg EPS beat(4)14.67%
Min EPS beat(4)-3.81%
Max EPS beat(4)36.58%
EPS beat(8)5
Avg EPS beat(8)-5.56%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-24.67%
Min Revenue beat(2)-30.53%
Max Revenue beat(2)-18.81%
Revenue beat(4)0
Avg Revenue beat(4)-15.43%
Min Revenue beat(4)-30.53%
Max Revenue beat(4)-5.16%
Revenue beat(8)0
Avg Revenue beat(8)-21.15%
Revenue beat(12)0
Avg Revenue beat(12)-24.04%
Revenue beat(16)2
Avg Revenue beat(16)-16.73%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.04
P/FCF N/A
P/OCF N/A
P/B 1.51
P/tB 1.51
EV/EBITDA N/A
EPS(TTM)-9.97
EYN/A
EPS(NY)-6.36
Fwd EYN/A
FCF(TTM)-3.5
FCFYN/A
OCF(TTM)-3.45
OCFYN/A
SpS1.06
BVpS1.43
TBVpS1.43
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -188.65%
ROE -246.28%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 54.07%
FCFM N/A
ROA(3y)-145.81%
ROA(5y)-129.68%
ROE(3y)-183.8%
ROE(5y)-169.9%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.57%
GM growth 5Y13.61%
F-Score3
Asset Turnover0.57
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 53.85%
Cap/Sales 4.52%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.01
Quick Ratio 3.6
Altman-Z -60.04
F-Score3
WACC9.79%
ROIC/WACCN/A
Cap/Depr(3y)86.22%
Cap/Depr(5y)65.99%
Cap/Sales(3y)11.23%
Cap/Sales(5y)18.53%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)96.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%86.49%
EPS Next Y36.16%
EPS Next 2Y18.6%
EPS Next 3Y14.28%
EPS Next 5YN/A
Revenue 1Y (TTM)55.4%
Revenue growth 3Y45.73%
Revenue growth 5Y67.7%
Sales Q2Q%69.83%
Revenue Next Year103.47%
Revenue Next 2Y91.38%
Revenue Next 3Y76.45%
Revenue Next 5YN/A
EBIT growth 1Y19.23%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year33.9%
EBIT Next 3Y19.27%
EBIT Next 5YN/A
FCF growth 1Y20.71%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y20.26%
OCF growth 3YN/A
OCF growth 5YN/A